Get startedLog in
    Picture of Solvonis Therapeutics logo

    SVNS — Solvonis Therapeutics News Story

    0.000.00%
    gb flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapSucker Stock
    All News

    Brief: Solvonis Therapeutics Initiates Studies For SVN-002 To Support 505(B)(2) Pathway And Advance Towards Phase 2B Trial

    Picture of Solvonis Therapeutics logoSolvonis Therapeutics
    22/07/2025 07:47
    July 22 (Reuters) - Solvonis Therapeutics PLC SVNS.L:

SOLVONIS THERAPEUTICS PLC - INITIATES STUDIES FOR SVN-002 TO SUPPORT 505(B)(2) PATHWAY AND ADVANCE TOWARDS PHASE 2B TRIAL

Source text: ID:nRSV9498Ra

Further company coverage: SVNS.L

 ((( Reuters.Briefs@thomsonreuters.com );))

    Recent news on Solvonis Therapeutics

    See all news